India's Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose
- Futures dip as focus turns to retail earnings
- Bitcoin (BTC) Hits 3-Month Lows Before Bouncing as Musk Confirms Tesla Has Not Sold Any BTC
- AT&T (T) in Talks to Merge Media Assets with Discovery (DISCA) - WSJ
- Bill Gates Left Microsoft (MSFT) Board Amid Probe Into 'Intimate Relationship': WSJ
- Oil prices stable on confidence in demand recovery
FILE PHOTO: Officials unload boxes containing vials of AstraZeneca's COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, outside a vaccination storage centre in Ahmedabad, India, January 12, 2021. REUTERS/Amit D
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
NEW DELHI (Reuters) - The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95).
"Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity," it said in a statement. "We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems."
($1 = 75.4620 Indian rupees)
(Reporting by Krishna N. Das and Euan Rocha, editing by Louise Heavens)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- France, Germany and Spain strike deal over joint combat jet
- Irish ransomware attack to cost health service tens of millions of euros
- U.S. military offers J&J vaccines for South Korean troops
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!